These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 953990)
21. Effects of methotrexate and of the "nonclassical" folate antagonist trimetrexate on human leukemia cells. Rodenhuis S; McGuire JJ; Sawicki WL; Bertino JR Leukemia; 1987 Feb; 1(2):116-20. PubMed ID: 2959824 [TBL] [Abstract][Full Text] [Related]
22. [Clinical pharmacology of anticancer agents [Part 5] Antimetabolites (2)]. Nakamura T; Ueda T; Uchida M Gan To Kagaku Ryoho; 1992 Mar; 19(3):409-20. PubMed ID: 1543370 [TBL] [Abstract][Full Text] [Related]
23. In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells. Wosikowski K; Biedermann E; Rattel B; Breiter N; Jank P; Löser R; Jansen G; Peters GJ Clin Cancer Res; 2003 May; 9(5):1917-26. PubMed ID: 12738750 [TBL] [Abstract][Full Text] [Related]
24. Methotrexate preconditioning allows sufficient engraftment to confer drug resistance in mice transplanted with marrow expressing drug-resistant dihydrofolate reductase activity. Belur LR; James RI; May C; Diers MD; Swanson D; Gunther R; McIvor RS J Pharmacol Exp Ther; 2005 Aug; 314(2):668-74. PubMed ID: 15857949 [TBL] [Abstract][Full Text] [Related]
25. Methotrexate cytotoxicity in cultured human leukemic cells studied by flow cytometry. Taylor IW; Tattersall MH Cancer Res; 1981 Apr; 41(4):1549-58. PubMed ID: 6163527 [TBL] [Abstract][Full Text] [Related]
26. Dihydrofolate reductase binding and cellular uptake of nonpolyglutamatable antifolates: correlates of cytotoxicity toward methotrexate-sensitive and -resistant human head and neck squamous carcinoma cells. Chen G; Wright JE; Rosowsky A Mol Pharmacol; 1995 Oct; 48(4):758-65. PubMed ID: 7476904 [TBL] [Abstract][Full Text] [Related]
27. Biochemical and growth inhibitory effects of the erythro and threo isomers of gamma-fluoromethotrexate, a methotrexate analogue defective in polyglutamylation. McGuire JJ; Graber M; Licato N; Vincenz C; Coward JK; Nimec Z; Galivan J Cancer Res; 1989 Aug; 49(16):4517-25. PubMed ID: 2472880 [TBL] [Abstract][Full Text] [Related]
28. N10-propargyl-5,8-dideazafolic acid (CB3717): inhibitory effects on human leukemia cell lines resistant to methotrexate or trimetrexate. Takemura Y; Ohnuma T Mt Sinai J Med; 1992 Oct; 59(5):419-24. PubMed ID: 1435841 [TBL] [Abstract][Full Text] [Related]
29. Determinants of the sensitivity of human small-cell lung cancer cell lines to methotrexate. Curt GA; Jolivet J; Carney DN; Bailey BD; Drake JC; Clendeninn NJ; Chabner BA J Clin Invest; 1985 Oct; 76(4):1323-9. PubMed ID: 2414316 [TBL] [Abstract][Full Text] [Related]
30. Comparison of triazines as inhibitors of L1210 dihydrofolate reductase and of L1210 cells sensitive and resistant to methotrexate. Selassie CD; Strong CD; Hansch C; Delcamp TJ; Freisheim JH; Khwaja TA Cancer Res; 1986 Feb; 46(2):744-56. PubMed ID: 3940640 [TBL] [Abstract][Full Text] [Related]
31. Antitumor activity of antifolate inhibitors of thymidylate and purine synthesis in human soft tissue sarcoma cell lines with intrinsic resistance to methotrexate. Li WW; Tong WP; Bertino JR Clin Cancer Res; 1995 Jun; 1(6):631-6. PubMed ID: 9816025 [TBL] [Abstract][Full Text] [Related]
32. Functional activity of the reduced folate carrier in KB, MA104, and IGROV-I cells expressing folate-binding protein. Westerhof GR; Rijnboutt S; Schornagel JH; Pinedo HM; Peters GJ; Jansen G Cancer Res; 1995 Sep; 55(17):3795-802. PubMed ID: 7641196 [TBL] [Abstract][Full Text] [Related]
33. Threshold methotrexate concentration for in vivo inhibition of DNA synthesis in normal and tumorous target tissues. Chabner BA; Young RC J Clin Invest; 1973 Aug; 52(8):1804-11. PubMed ID: 4719662 [TBL] [Abstract][Full Text] [Related]
34. Biochemical and cell cycle perturbations in methotrexate-treated cells. Taylor IW; Slowiaczek P; Francis PR; Tattersall MH Mol Pharmacol; 1982 Jan; 21(1):204-10. PubMed ID: 6982394 [TBL] [Abstract][Full Text] [Related]
35. Novel 6,5-fused ring heterocyclic antifolates: biochemical and biological characterization. McGuire JJ; Bergoltz VV; Heitzman KJ; Haile WH; Russell CA; Bolanowska WE; Kotake Y; Haneda T; Nomura H Cancer Res; 1994 May; 54(10):2673-9. PubMed ID: 8168096 [TBL] [Abstract][Full Text] [Related]
36. Antifolate analogs: mechanism of action, analytical methodology, and clinical efficacy. Fleisher M Ther Drug Monit; 1993 Dec; 15(6):521-6. PubMed ID: 8122287 [TBL] [Abstract][Full Text] [Related]
37. Osteosarcoma cells, resistant to methotrexate due to nucleoside and nucleobase salvage, are sensitive to nucleoside analogs. Cole PD; Smith AK; Kamen BA Cancer Chemother Pharmacol; 2002 Aug; 50(2):111-6. PubMed ID: 12172974 [TBL] [Abstract][Full Text] [Related]
38. Identification of a membrane-associated folate-binding protein in human leukemic CCRF-CEM cells with transport-related methotrexate resistance. Jansen G; Westerhof GR; Kathmann I; Rademaker BC; Rijksen G; Schornagel JH Cancer Res; 1989 May; 49(9):2455-9. PubMed ID: 2706633 [TBL] [Abstract][Full Text] [Related]
39. Intracellular pharmacokinetics of methotrexate polyglutamates in human breast cancer cells. Selective retention and less dissociable binding of 4-NH2-10-CH3-pteroylglutamate4 and 4-NH2-10-CH3-pteroylglutamate5 to dihydrofolate reductase. Jolivet J; Chabner BA J Clin Invest; 1983 Sep; 72(3):773-8. PubMed ID: 6193143 [TBL] [Abstract][Full Text] [Related]
40. [The metabolism of high-molecular-weight substances in cells and the effect of anticancer drugs]. Kanamaru R; Kakuta H; Sato T; Ishioka C; Konishi Y; Wakui A; Dei T Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):837-44. PubMed ID: 3566294 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]